New Research Reveals Genetic Overlap Between COPD and Lung Cancer Susceptibility

New Orleans – May 17, 2010 – New research shows genes that make smokers more likely to develop chronic obstructive pulmonary disease (COPD), or emphysema, are also closely linked to an increased likelihood of developing lung cancer, according to studies presented today at the American Thoracic Society’s annual meeting.

Tests Showing Smokers Their Individual Risk Of Future Disease Will Help Them Quit, Says Paper

Personalizing Risk To Prompt Lifestyle Changes Good Model For Improving Smoking Cessation

Research Shows Efforts To Quit Smoking Strengthen After Personalized Lung Cancer Risk Test

HOUSTON, Dec. 8 - Smokers who see their own personal risk of developing lung cancer after genetic-based testing show stronger intention and take more action on quitting smoking, according to cli...

Personalized, Gene-Based Risk Testing For Lung Cancer Gives New Tool To Help Smokers Quit

Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.

PHD Diagnostics Introduces First Gene-Based Test to Predict Individual Lung Cancer Risk

Respiragene™ Test Offers Personalized Assessment of Susceptibility

NZ-developed lung cancer risk test launched in UK

The New Zealand-developed genetic lung cancer risk test, Respiragene™, has been launched in the UK by European market-leader Lab 21, a specialist in predictive, personalised diagnostics.